Skip to main content
GlobalSpace Technologies Limited logo

GlobalSpace Technologies Limited — Investor Relations & Filings

Ticker · 540654 ISIN · INE632W01016 LEI · 9845000BF714B500BF22 BSE.NS Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-06-01 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS 540654

About GlobalSpace Technologies Limited

https://www.globalspace.in/

GlobalSpace Technologies Limited develops digital transformation solutions primarily focused on the healthcare and pharmaceutical sectors. The company provides an integrated ecosystem of software platforms designed to enhance the interaction between medical professionals, patients, and pharmaceutical enterprises. Key offerings include DocExa, a digital clinic management and teleconsultation platform, and V-Pharma, a specialized sales force automation and customer relationship management tool. These solutions leverage cloud computing and mobility to streamline clinical workflows, improve patient engagement, and optimize commercial operations for pharmaceutical companies. By integrating data-driven insights and mobile-first technology, the company facilitates end-to-end digital adoption for healthcare providers and life sciences organizations.

Recent filings

Filing Released Lang Actions
This is with reference to our intimation dated May 15, 2026, submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding ....
Share Issue/Capital Change Classification · 75% confidence The document is a correction (“clarification regarding typographical error”) to a prior SEBI LODR Regulation 30 intimation concerning the grant of employee stock options under the Company’s ESOP scheme. This is an announcement of a capital change (new option issue) rather than a financial report, earnings release, or governance notice. Under our taxonomy, ESOP grants (share option issuances) are classified as Share Issue/Capital Change (SHA).
2026-06-01 English
Annual Secretarial Compliance Report for the year ended March 2026
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report issued by a Practicing Company Secretary under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a compliance certificate/attestation rather than a full financial report, earnings release, management discussion, or any of the other specific filings. Under the CERTIFICATION RULE, officer certifications and compliance attestations should be classified as general regulatory filings. Therefore, the correct classification is RNS (Regulatory Filings).
2026-05-29 English
Pursuant to provisions of Regulation 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 please find enclosed the copy of newspaper ....
Report Publication Announcement Classification · 88% confidence The document is a short letter to the stock exchange under SEBI LODR Regulations 33 and 47, enclosing newspaper advertisements of the audited financial results. It does not contain the actual financial statements or detailed results but merely announces that the audited results have been published (copies attached/available). This meets the definition of a Report Publication Announcement (RPA), rather than the full Annual or Interim Report itself.
2026-05-17 English
Pursuant to provision of Regulation 30 of LODR, Nomination and Remuneration Committee has approved grant of 4,90,000 Options to the Eligible Employee under "Global space Technologies Limited ....
Regulatory Filings
2026-05-15 English
The Appointment of Ms. Tania Mazumdar as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP)of the company.
Board/Management Information Classification · 89% confidence The document is an SEBI Listing Regulations compliance filing notifying the stock exchange of the outcome of a Board meeting held May 15, 2026. It covers board approvals of audited financial results, re-appointment of the internal auditor, appointment of a new CEO/KMP, and stock-option grants. It is not the full annual or interim report itself (no detailed financial statements or management discussion), but rather a management/board announcement of decisions and appointments. This falls squarely under Board/Management Information (code MANG).
2026-05-15 English
The Re-Appointment of M/s. Maheshwari Maheshwari & Co., Practicing Chartered Accountants (FRN: 105838W) as an Internal Auditor of the Company for the financial year 2026-27.
Audit Report / Information Classification · 85% confidence The document is a SEBI Reg.30/33 disclosure of Board meeting outcomes, notably including the audited quarterly and year‐to‐date standalone financial results and the accompanying Independent Auditor’s Report. It is not the full Annual Report, nor merely an announcement of report publication, but the actual audit report on the financial results. This fits the standalone Audit Report / Information category. FY 2026
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.